NRG4 and metabolic syndrome: We found that the path from adiposity and MetS was protectively mediated Nrg4 but adversely mediated by adipsin, suggesting that elevating circulating Nrg4 levels and inhibiting adipsin secreting might be therapeutic potentials for protecting obesity from MetS.